Background There has been an increase in 'risk sharing' schemes for pharmaceuticals
between healthcare institutions and pharmaceutical companies in Europe in recent years as an …

Drug regulatory agencies should ensure that the benefits of drugs outweigh their risks, but
licensed medicines sometimes do not perform as expected in everyday clinical practice. …

Aim: the aim of this article was to evaluate the influence of different demand-side measures
to enhance the prescribing of generics in ambulatory care based on cross-national …

The Swedish Society of Anaesthetists conducted a nationwide retrospective survey of clinical
experience with extradural and intrathecal opiates Special interest was focused on the …

1 Chloroquine was given in 300 mg single doses as an iv infusion, an oral solution and as
tablets at intervals of at least 56 days to 11 healthy volunteers. Concentrations of chloroquine …

The aim was to present and evaluate the impact of a comprehensive strategy over 10 years
to select, communicate and achieve adherence to essential drug recommendations (EDR) in …

Objective Knowledge about the metabolism of anti-parasitic drugs (APDs) will be helpful in
ongoing efforts to optimise dosage recommendations in clinical practise. This study was …

Objective The aim was to develop a drug-drug interaction database (SFINX) to be integrated
into decision support systems or to be used in website solutions for clinical evaluation of …

It is a continual challenge trying to improve the quality of prescribing while concurrently trying
to address increasing pharmaceutical development, utilization and expenditure. National …

… Godman B, Gustafsson LL. A new reimbursement system for innovative pharmaceuticals
combining value-based and free market pricing. Appl Health Econ Health Policy 2013;11(1):79-…